Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

[Uveitis in multiple sclerosis : Overview and perspectives.]
Genetic targeting of microglia.
Isolated new onset 'atypical' optic neuritis in the NMO clinic: serum antibodies, prognoses and diagnoses at follow-up.
Dynamometer-based measure of spasticity confirms limited association between plantarflexor spasticity and walking function in persons with multiple sclerosis.
Perspectives on Physical Activity Among People with Multiple Sclerosis Who Are Wheelchair Users: Informing the Design of Future Interventions.
Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate.
Month of birth, vitamin D and risk of immune mediated disease: a case control study.
Case of Type 1 Diabetes Mellitus Following Interferon β-1a Treatment for Multiple Sclerosis.
Tertiary lymphoid organ development coincides with determinant spreading of the myelin-specific T cell response.
Identifying and treating pain caused by MS.
Chondroitin sulfate proteoglycans in demyelinated lesions impair remyelination.
Regional Heterogeneity of Cuprizone-Induced Demyelination: Topographical Aspects of the Midline of the Corpus Callosum.
Risk of fractures in patients with multiple sclerosis: record-linkage study.
Natalizumab in the treatment of pediatric multiple sclerosis.
Glia Maturation Factor Induces Interleukin-33 Release from Astrocytes: Implications for Neurodegenerative Diseases.
Positive Effect on Multiple Sclerosis With Treatment of Metabolic Syndrome.
Intracisternal delivery of AAV9 results in oligodendrocyte and motor neuron transduction in the whole central nervous system of cats.
Quantitative assessment of upper limb motor function in Multiple Sclerosis using an instrumented Action Research Arm Test.
Should we feel free to use loco-regional anesthesia in multiple sclerosis?
The blood-brain barrier-permeable catechol-O-methyltransferase inhibitor dinitrocatechol suppresses experimental autoimmune encephalomyelitis.
Brain-specific knockdown of miR-29 results in neuronal cell death and ataxia in mice.
Are specialty drug prices destroying insurers and hurting consumers?: a number of efforts are under way to reduce price pressure.
Diagnosis and differential diagnosis of multiple sclerosis.
Regulation of cerebrospinal fluid (CSF) flow in neurodegenerative, neurovascular and neuroinflammatory disease.
Enzymatic deglycosylation converts pathogenic neuromyelitis optica anti-aquaporin-4 immunoglobulin G into therapeutic antibody.

Pages